List Name |
Annotation |
Enrichment |
p-value |
organ development |
AmiGO Browser |
3.03 |
5.06e-04 |
regulation of isotype switching |
AmiGO Browser |
44.95 |
9.11e-04 |
mesoderm development |
AmiGO Browser |
14.80 |
1.16e-03 |
positive regulation of B cell activation |
AmiGO Browser |
32.36 |
1.77e-03 |
multicellular organismal development |
AmiGO Browser |
2.27 |
1.94e-03 |
somatic recombination of immunoglobulin genes during immune response |
AmiGO Browser |
26.97 |
2.54e-03 |
isotype switching |
AmiGO Browser |
26.97 |
2.54e-03 |
somatic diversification of immunoglobulins during immune response |
AmiGO Browser |
26.97 |
2.54e-03 |
immunoglobulin production during immune response |
AmiGO Browser |
26.97 |
2.54e-03 |
somatic cell DNA recombination |
AmiGO Browser |
26.10 |
2.71e-03 |
somatic diversification of immune receptors via germline recombination within a single locus |
AmiGO Browser |
26.10 |
2.71e-03 |
somatic recombination of immunoglobulin gene segments |
AmiGO Browser |
26.10 |
2.71e-03 |
system development |
AmiGO Browser |
2.40 |
2.83e-03 |
somatic diversification of immunoglobulins |
AmiGO Browser |
23.80 |
3.25e-03 |
somatic diversification of immune receptors |
AmiGO Browser |
23.80 |
3.25e-03 |
circadian rhythm |
AmiGO Browser |
23.80 |
3.25e-03 |
mesoderm formation |
AmiGO Browser |
21.29 |
4.05e-03 |
regulation of B cell activation |
AmiGO Browser |
21.29 |
4.05e-03 |
immunoglobulin production |
AmiGO Browser |
20.75 |
4.26e-03 |
formation of primary germ layer |
AmiGO Browser |
20.23 |
4.48e-03 |
mesoderm morphogenesis |
AmiGO Browser |
20.23 |
4.48e-03 |
anatomical structure formation |
AmiGO Browser |
6.11 |
4.50e-03 |
insulin receptor signaling pathway |
AmiGO Browser |
15.86 |
7.19e-03 |
production of molecular mediator of immune response |
AmiGO Browser |
15.86 |
7.19e-03 |
erythrocyte differentiation |
AmiGO Browser |
14.98 |
8.03e-03 |
regulation of Ras GTPase activity |
AmiGO Browser |
13.26 |
0.01 |
gastrulation |
AmiGO Browser |
13.26 |
0.01 |
positive regulation of cell proliferation |
AmiGO Browser |
4.79 |
0.01 |
brain development |
AmiGO Browser |
6.63 |
0.01 |
tissue morphogenesis |
AmiGO Browser |
12.26 |
0.01 |
response to external stimulus |
AmiGO Browser |
3.20 |
0.01 |
anatomical structure development |
AmiGO Browser |
2.00 |
0.01 |
transcription from RNA polymerase II promoter |
AmiGO Browser |
2.84 |
0.01 |
negative regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
6.04 |
0.01 |
regulation of actin filament length |
AmiGO Browser |
11.08 |
0.01 |
organ morphogenesis |
AmiGO Browser |
3.55 |
0.01 |
positive regulation of lymphocyte activation |
AmiGO Browser |
10.37 |
0.02 |
immunoglobulin mediated immune response |
AmiGO Browser |
10.24 |
0.02 |
B cell mediated immunity |
AmiGO Browser |
10.24 |
0.02 |
segment specification |
AmiGO Browser |
57.79 |
0.02 |
embryonic development |
AmiGO Browser |
4.08 |
0.02 |
male gamete generation |
AmiGO Browser |
5.39 |
0.02 |
spermatogenesis |
AmiGO Browser |
5.39 |
0.02 |
regulation of interleukin-6 biosynthetic process |
AmiGO Browser |
50.57 |
0.02 |
regulation of hydrolase activity |
AmiGO Browser |
5.28 |
0.02 |
negative regulation of cell differentiation |
AmiGO Browser |
8.99 |
0.02 |
mesodermal cell differentiation |
AmiGO Browser |
44.95 |
0.02 |
mesodermal cell fate commitment |
AmiGO Browser |
44.95 |
0.02 |
regulation of Rho GTPase activity |
AmiGO Browser |
44.95 |
0.02 |
cellular response to extracellular stimulus |
AmiGO Browser |
44.95 |
0.02 |
negative regulation of small GTPase mediated signal transduction |
AmiGO Browser |
44.95 |
0.02 |
cellular response to starvation |
AmiGO Browser |
44.95 |
0.02 |
cellular response to nutrient levels |
AmiGO Browser |
44.95 |
0.02 |
rhythmic process |
AmiGO Browser |
8.61 |
0.02 |
blood vessel morphogenesis |
AmiGO Browser |
4.89 |
0.02 |
positive regulation of B cell proliferation |
AmiGO Browser |
40.45 |
0.02 |
response to starvation |
AmiGO Browser |
40.45 |
0.02 |
interleukin-6 biosynthetic process |
AmiGO Browser |
40.45 |
0.02 |
interleukin-6 production |
AmiGO Browser |
40.45 |
0.02 |
negative regulation of transcription |
AmiGO Browser |
3.69 |
0.02 |
multicellular organismal process |
AmiGO Browser |
1.68 |
0.03 |
cell proliferation |
AmiGO Browser |
2.45 |
0.03 |
positive regulation of lipid metabolic process |
AmiGO Browser |
36.78 |
0.03 |
negative regulation of cell-cell adhesion |
AmiGO Browser |
36.78 |
0.03 |
negative regulation of B cell activation |
AmiGO Browser |
36.78 |
0.03 |
oligopeptide transport |
AmiGO Browser |
36.78 |
0.03 |
regulation of cell-matrix adhesion |
AmiGO Browser |
33.71 |
0.03 |
positive regulation of isotype switching |
AmiGO Browser |
33.71 |
0.03 |
placenta development |
AmiGO Browser |
33.71 |
0.03 |
negative regulation of developmental process |
AmiGO Browser |
7.36 |
0.03 |
anatomical structure morphogenesis |
AmiGO Browser |
2.22 |
0.03 |
regulation of transcription from RNA polymerase II promoter |
AmiGO Browser |
2.89 |
0.03 |
regulation of cell-cell adhesion |
AmiGO Browser |
31.12 |
0.03 |
regulation of T-helper cell differentiation |
AmiGO Browser |
31.12 |
0.03 |
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
3.39 |
0.03 |
regulation of lymphocyte activation |
AmiGO Browser |
7.10 |
0.03 |
regulation of GTPase activity |
AmiGO Browser |
7.10 |
0.03 |
B cell activation |
AmiGO Browser |
7.04 |
0.03 |
lymphocyte mediated immunity |
AmiGO Browser |
6.97 |
0.03 |
blood vessel development |
AmiGO Browser |
4.29 |
0.03 |
neuromuscular synaptic transmission |
AmiGO Browser |
28.90 |
0.03 |
regulation of production of molecular mediator of immune response |
AmiGO Browser |
28.90 |
0.03 |
cytokine production during immune response |
AmiGO Browser |
28.90 |
0.03 |
regulation of cytokine production during immune response |
AmiGO Browser |
28.90 |
0.03 |
regulation of cell activation |
AmiGO Browser |
6.92 |
0.03 |
vasculature development |
AmiGO Browser |
4.21 |
0.04 |
adaptive immune response |
AmiGO Browser |
6.80 |
0.04 |
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
AmiGO Browser |
6.80 |
0.04 |
positive regulation of biological process |
AmiGO Browser |
2.16 |
0.04 |
cellular response to stimulus |
AmiGO Browser |
26.97 |
0.04 |
tubulin folding |
AmiGO Browser |
26.97 |
0.04 |
negative regulation of transcription, DNA-dependent |
AmiGO Browser |
4.16 |
0.04 |
leukocyte mediated immunity |
AmiGO Browser |
6.52 |
0.04 |
gamete generation |
AmiGO Browser |
4.09 |
0.04 |
regulation of B cell proliferation |
AmiGO Browser |
25.28 |
0.04 |
developmental process |
AmiGO Browser |
1.62 |
0.04 |
alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
T cell activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
leukocyte activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
lymphocyte activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
cell activation during immune response |
AmiGO Browser |
23.80 |
0.04 |
T cell differentiation during immune response |
AmiGO Browser |
23.80 |
0.04 |
T-helper cell differentiation |
AmiGO Browser |
23.80 |
0.04 |
actin cytoskeleton organization and biogenesis |
AmiGO Browser |
3.88 |
0.04 |
regulation of immune system process |
AmiGO Browser |
6.04 |
0.04 |
regulation of immune response |
AmiGO Browser |
6.04 |
0.04 |
negative regulation of cellular metabolic process |
AmiGO Browser |
3.02 |
0.05 |
CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
21.29 |
0.05 |
nervous system development |
AmiGO Browser |
2.32 |
0.05 |
negative regulation of immune response |
AmiGO Browser |
20.23 |
0.05 |
negative regulation of immune system process |
AmiGO Browser |
20.23 |
0.05 |
T-helper 2 type immune response |
AmiGO Browser |
20.23 |
0.05 |
regulation of immune effector process |
AmiGO Browser |
20.23 |
0.05 |
myeloid cell differentiation |
AmiGO Browser |
5.70 |
0.05 |
immune effector process |
AmiGO Browser |
5.66 |
0.05 |
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
1.73 |
0.05 |
central nervous system development |
AmiGO Browser |
3.66 |
0.05 |
response to metal ion |
AmiGO Browser |
19.26 |
0.05 |
regulation of transcription, DNA-dependent |
AmiGO Browser |
1.77 |
0.05 |
actin filament-based process |
AmiGO Browser |
3.58 |
0.05 |
transmembrane receptor protein tyrosine phosphatase signaling pathway |
AmiGO Browser |
18.39 |
0.05 |
positive regulation of metabolic process |
AmiGO Browser |
2.85 |
0.05 |
glucose metabolic process |
AmiGO Browser |
5.39 |
0.05 |
negative regulation of cellular process |
AmiGO Browser |
1.97 |
0.05 |
sexual reproduction |
AmiGO Browser |
3.53 |
0.05 |
negative regulation of apoptosis |
AmiGO Browser |
3.52 |
0.06 |
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. |
AmiGO Browser |
17.59 |
0.06 |
regulation of T cell differentiation |
AmiGO Browser |
17.59 |
0.06 |
positive regulation of angiogenesis |
AmiGO Browser |
17.59 |
0.06 |
regulation of adaptive immune response |
AmiGO Browser |
17.59 |
0.06 |
immune system development |
AmiGO Browser |
3.51 |
0.06 |
cytokine production |
AmiGO Browser |
5.29 |
0.06 |
negative regulation of programmed cell death |
AmiGO Browser |
3.50 |
0.06 |
positive regulation of cellular process |
AmiGO Browser |
2.07 |
0.06 |
regulation of metabolic process |
AmiGO Browser |
1.65 |
0.06 |
DNA recombination |
AmiGO Browser |
5.12 |
0.06 |
regulation of defense response |
AmiGO Browser |
16.18 |
0.06 |
regulation of inflammatory response |
AmiGO Browser |
16.18 |
0.06 |
positive regulation of locomotion |
AmiGO Browser |
16.18 |
0.06 |
positive regulation of cell motility |
AmiGO Browser |
16.18 |
0.06 |
transcription, DNA-dependent |
AmiGO Browser |
1.72 |
0.06 |
RNA biosynthetic process |
AmiGO Browser |
1.72 |
0.06 |
regulation of erythrocyte differentiation |
AmiGO Browser |
15.56 |
0.06 |
neural crest cell migration |
AmiGO Browser |
15.56 |
0.06 |
regulation of mRNA stability |
AmiGO Browser |
15.56 |
0.06 |
negative regulation of biological process |
AmiGO Browser |
1.91 |
0.06 |
regulation of RNA stability |
AmiGO Browser |
14.98 |
0.06 |
B cell proliferation |
AmiGO Browser |
14.98 |
0.06 |
negative regulation of myeloid cell differentiation |
AmiGO Browser |
14.98 |
0.06 |
response to inorganic substance |
AmiGO Browser |
14.98 |
0.06 |
male gonad development |
AmiGO Browser |
14.98 |
0.06 |
alpha-beta T cell differentiation |
AmiGO Browser |
14.45 |
0.07 |
negative regulation of metabolic process |
AmiGO Browser |
2.63 |
0.07 |
inflammatory response |
AmiGO Browser |
3.17 |
0.07 |
vasculogenesis |
AmiGO Browser |
13.48 |
0.07 |
regulation of lymphocyte differentiation |
AmiGO Browser |
13.48 |
0.07 |
development of primary male sexual characteristics |
AmiGO Browser |
13.05 |
0.07 |
prostaglandin metabolic process |
AmiGO Browser |
13.05 |
0.07 |
prostanoid metabolic process |
AmiGO Browser |
13.05 |
0.07 |
fat cell differentiation |
AmiGO Browser |
13.05 |
0.07 |
regulation of response to stimulus |
AmiGO Browser |
12.64 |
0.08 |
regulation of transcription |
AmiGO Browser |
1.65 |
0.08 |
regulation of lipid metabolic process |
AmiGO Browser |
12.26 |
0.08 |
neural crest cell development |
AmiGO Browser |
12.26 |
0.08 |
peripheral nervous system development |
AmiGO Browser |
12.26 |
0.08 |
neural crest cell differentiation |
AmiGO Browser |
12.26 |
0.08 |
regulation of cellular metabolic process |
AmiGO Browser |
1.60 |
0.08 |
negative regulation of lymphocyte activation |
AmiGO Browser |
11.90 |
0.08 |
regulation of RNA metabolic process |
AmiGO Browser |
11.56 |
0.08 |
alpha-beta T cell activation |
AmiGO Browser |
11.24 |
0.09 |
tissue development |
AmiGO Browser |
2.90 |
0.09 |
regulation of endocytosis |
AmiGO Browser |
10.93 |
0.09 |
segmentation |
AmiGO Browser |
10.65 |
0.09 |
mesenchymal cell development |
AmiGO Browser |
10.65 |
0.09 |
negative regulation of cell adhesion |
AmiGO Browser |
10.65 |
0.09 |
regulation of Ras protein signal transduction |
AmiGO Browser |
4.01 |
0.09 |
protein amino acid dephosphorylation |
AmiGO Browser |
3.99 |
0.09 |
regulation of cytokine production |
AmiGO Browser |
10.37 |
0.09 |
mesenchymal cell differentiation |
AmiGO Browser |
10.37 |
0.09 |
enzyme linked receptor protein signaling pathway |
AmiGO Browser |
2.77 |
0.10 |
positive regulation of transcription |
AmiGO Browser |
2.76 |
0.10 |
protein amino acid ADP-ribosylation |
AmiGO Browser |
9.87 |
0.10 |
male sex differentiation |
AmiGO Browser |
9.87 |
0.10 |
embryonic pattern specification |
AmiGO Browser |
9.87 |
0.10 |
regulation of translation |
AmiGO Browser |
3.83 |
0.10 |
transcription |
AmiGO Browser |
1.57 |
0.10 |
angiogenesis |
AmiGO Browser |
3.82 |
0.10 |
inner ear morphogenesis |
AmiGO Browser |
9.63 |
0.10 |
regulation of cell proliferation |
AmiGO Browser |
2.30 |
0.10 |
hexose metabolic process |
AmiGO Browser |
3.76 |
0.10 |
regulation of cellular process |
AmiGO Browser |
1.40 |
0.10 |
positive regulation of lymphocyte proliferation |
AmiGO Browser |
9.41 |
0.10 |
regulation of Rab protein signal transduction |
AmiGO Browser |
9.41 |
0.10 |
positive regulation of mononuclear cell proliferation |
AmiGO Browser |
9.41 |
0.10 |
regulation of Rab GTPase activity |
AmiGO Browser |
9.41 |
0.10 |
response to nutrient levels |
AmiGO Browser |
9.41 |
0.10 |
peptide transport |
AmiGO Browser |
9.41 |
0.10 |
Rab protein signal transduction |
AmiGO Browser |
9.41 |
0.10 |
response to hypoxia |
AmiGO Browser |
9.41 |
0.10 |
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process |
AmiGO Browser |
2.70 |
0.10 |
acute-phase response |
AmiGO Browser |
9.19 |
0.10 |
response to stimulus |
AmiGO Browser |
1.56 |
0.10 |
monosaccharide metabolic process |
AmiGO Browser |
3.68 |
0.10 |